Ep. 325 – Frankly Speaking: INO, Buy or Sell Side Analysts, Reverse ETF’s and Stops

We start today with three questions from Clark. First, he asks about the difference between buy-side and sell-side analysts.

Second, he’d like to know about why and when companies release their earnings reports.

And third, he’d like to know about my special offer.

[app_audio src=”http://traffic.libsyn.com/sainvestorradio/Frankly20Speaking20EP20325.mp3″]

TJ wrote in to ask about the pharmaceutical company Inovio Pharmaceuticals, Inc. (INO) and to get my opinion on Tim Sykes.

Steve would like my opinion on reverse ETF’s if the market does come down.

Then Robert writes in to comment on biases in research and to ask  about the risks of setting stops.

Finally, Agustin has a question about a penny stock he’s interested in. They’ve received a government contract recently and he wants to know if it’s smart to put a $1000 into a stock like this and hope for the best.

As always, thanks for listening and good investing!

RECENT EPISODES

oil market

How to profit from today’s volatile oil market

Steve Koomar is back to share his views on the Saudi oilfield attack. He also gives you some of his favorite energy names to buy right now... and which to avoid. Plus, Frank debunks the theory that higher oil prices will derail the U.S. consumer… and tells you how to invest in this volatile sector without a lot of risk.
Listen Now
inflection point

Don’t be passive at an inflection point like this

Two things are on my mind today: energy security and passive investing. We’ll explore why they’re linked… and the inflection point that’s been quietly building in the markets. Now more than ever, you can’t afford to be passive…
Listen Now